Dana-Farber News

A podcast worth listening to: Dr. Kimmie Ng, director of @DFarberYoungCRC, joins JAMA Deputy Editor Dr. Kristin Walter to discuss current data on early-onset colorectal, pancreatic, and esophagogastric cancers. @JAMA_current @KimmieNgMD @DanaFarber bit.ly/40x56ZK

In a study, published in @CCR_AACR, @danafarber researcher @Jia_Luo uncovered the potential for underdiagnosis of NUT carcinoma and identified additional tests required for an accurate diagnosis. Read more: bit.ly/4nW4Ld4

.@DanaFarber’s Megan Insco, MD, PhD & colleagues have developed the first genetically engineered animal model of mucosal melanoma, a difficult subtype of the disease with few treatment options. The researchers are now using this model for therapeutic target discovery for MM and…

New paper published in Gynecologic Oncology from @DFCIGynOnc shows that targeting the RAS-MEK-ERK pathway offers exciting new opportunities for effective treatment of low-grade serous ovarian cancer. Further research is underway to optimize this strategy in LGSC. ➡️…

Congratulations to @DanaFarber's @DrMDavids who was awarded the 2025 @CllSociety Clinical Scholar Award for his work: Optimizing Glofitamab Combination Therapy in Richter’s Transformation. Read more: bit.ly/4eZLQtP

.@KimmieNgMD, director of @DFarberYoungCRC, spoke with @boston25 News today about the rising rates of gastrointestinal cancers, including colorectal, gastric, esophageal and pancreatic cancers, among younger adults. ➡️ bit.ly/3TNc2hz

Proof-of-concept: Epigenetic reprogramming could one day be a new therapeutic path in colorectal cancer. @Nilay_Sethi explains how histone acetylation shapes CRC cell fate in this @AGA_Gastro study: bit.ly/46gS7z1

GI cancers are now the fastest-growing types of cancer diagnosed in adults younger than 50 in the U.S. @KimmieNgMD co-authored the research review and spoke with @NBCNews about one of the most comprehensive looks at GI cancer trends. @DFarberYoungCRC bit.ly/3GSbdkC

Fewer than 1 in 5 U.S. adults screened for colorectal cancer, despite guidelines. This review in @JAMA_current by @DanaFarber charts a global rise of many GI cancers, noting colorectal cancer leads the alarming trend. @KimmieNgMD @ThejusJay @DFarberYoungCRC…

Genitourinary Cancers State of the Science Summit is in Boston on July 22: @CaPsurvivorship and @VincentWenxinXu are both presenting on new treatment approaches and strategies in genitourinary cancers. @DanaFarber_GU

What happens after cancer treatment ends? @DrVinayakV of @DanaFarber shares what survivorship really means—especially for young adults navigating rare cancers like sarcoma—on the @AllTalkOncology podcast. Full episode here: bit.ly/40i4Iyi

Thank you @CureSarcoma for featuring me in “Faces Behind the Ribbon” during July #SarcomaAwarenessMonth & for all you do to advocate & support those affected by #sarcoma! It’s an honor to care for people with #sarcoma & their families @DanaFarber @DanaFarberNews

In a study published in @CellCellPress, @DanaFarber researchers showed that a modified NeoVax cancer vaccine triggered strong immune responses in melanoma. Read more: bit.ly/44nz5Wp

Chromophobe renal cell carcinoma is difficult to treat - Research in @JCO_ASCO provides better understanding of this rare kidney cancer, potential treatment pathways & immunotherapy strategies. @DanaFarber_GU @eddy_saad @Chrislabaki1 @BIDMChealth ➡️ bit.ly/3IhLT8d

.@DanaFarber is proud to be among the institutions awarded funding from @LLSusa as part of its nearly $5 million investment to expand access to clinical trials for blood cancer patients. 🔗 Read more: bit.ly/4lcErcW

Honored to visit @WRNMMC_DHA to talk about all things #sarcoma + personalized exercise, and meet their incredible medical oncology team - as part of a new collaborative w/ @DanaFarber to share expertise + enhance cancer care for active & retired military members @DanaFarberNews

Another treatment option for metastatic prostate cancer - @DanaFarber's @PrafulRavi1 discusses PSMA-targeted therapy, which delivers radiation directly to cancer cells, in @CancerTodayMag by @AACR. @DanaFarber_GU Read more here: bit.ly/4nEGMz4

A new report from @DanaFarber highlights rising rates of GI cancers in young adults - not just #colorectal, but also #pancreatic, #esophageal, #gastric, #biliary & more. @DFarberYoungCRC @KimmieNgMD @SaraKCharMD @CatherineaOC Read more: bit.ly/40D0kd8

New research in @PNASNews led by @DanaFarber’s Yubao Wang, PhD, in the lab of Tom Roberts, PhD, explored an engineered, degradable form of a small viral protein and made new insights into a key cell growth pathway often hijacked by cancer cells. Read more:…